Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Consensus Statement:Benefits VS Risk of Medical Therapy for Acromegaly
Am J Med 97:468-473, Melmed,S.,et al, 1994
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983
Acute Quadriplegia in Acromegaly
Ann Int Med 117:94-95, Tanigawa,K.,et al, 1992
Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement
Ophthalmol 96:1038-1047, Patrinely,J.R.,et al, 1989
Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
NEJM 342:1871-1876, Beuschlein,F.,et al, 2000
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Octreotide
NEJM 334:246-254, Lamberts,S.W.J.,et al, 1996
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Long-term Treatment of 189 Acromegalic Patients with the Somatostatin Analog Octreotide
Arch Int Med 151:1573-1578, Vance,M.L.&Harris,A.G., 1991
Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
Ann Int Med 112:173-181, Ho,K.Y.,et al, 1990
Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973
Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972